DYADIC INTERNATIONAL INC Increase (Decrease) in Accounts Receivable
DYADIC INTERNATIONAL INC (DYAI) reported Increase (Decrease) in Accounts Receivable of $217.92 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-12
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $307.30K, a 36.92% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$89.38K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $173.66K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $201.44K, a 110.03% increase year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for fiscal 2025 was $846.96K.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for fiscal 2024 was -$219.43K, a 255.26% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for fiscal 2023 was $141.33K, a 69.74% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC increase (decrease) in accounts receivable for fiscal 2022 was $83.27K, a 161.91% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $307.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $217.92K 10-Q · filed 2026-08-12 | $391.58K derived: sum of 3 quarters · filed 2026-08-12 | $593.03K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$89.38K 10-Q · filed 2026-05-13 | $84.29K derived: sum of 2 quarters · filed 2026-05-13 | $285.73K derived: sum of 3 quarters · filed 2026-05-13 | $772.87K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $173.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $375.10K derived: sum of 2 quarters · filed 2026-03-25 | $862.24K derived: sum of 3 quarters · filed 2026-08-12 | $846.96K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $201.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $688.58K derived: sum of 2 quarters · filed 2026-08-12 | $673.30K 10-Q · filed 2025-11-12 | $568.69K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $487.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $471.86K 10-Q · filed 2026-08-12 | $367.25K derived: sum of 3 quarters · filed 2026-08-12 | $463.16K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$15.28K 10-Q · filed 2026-05-13 | -$119.89K derived: sum of 2 quarters · filed 2026-05-13 | -$23.98K derived: sum of 3 quarters · filed 2026-05-13 | -$18.32K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$104.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$8.70K derived: sum of 2 quarters · filed 2026-03-25 | -$3.04K derived: sum of 3 quarters · filed 2026-03-25 | -$219.43K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $95.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $101.57K derived: sum of 2 quarters · filed 2025-11-12 | -$114.81K 10-Q · filed 2025-11-12 | -$81.15K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $5.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$210.72K 10-Q · filed 2025-08-13 | -$177.06K derived: sum of 3 quarters · filed 2025-08-13 | -$499.18K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$216.38K 10-Q · filed 2025-05-14 | -$182.72K derived: sum of 2 quarters · filed 2025-05-14 | -$504.84K derived: sum of 3 quarters · filed 2025-05-14 | -$489.04K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $33.67K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$288.46K derived: sum of 2 quarters · filed 2025-03-26 | -$272.66K derived: sum of 3 quarters · filed 2025-03-26 | $141.33K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$322.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$306.32K derived: sum of 2 quarters · filed 2024-11-12 | $107.67K 10-Q · filed 2024-11-12 | $176.09K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $15.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $429.79K 10-Q · filed 2024-08-13 | $498.22K derived: sum of 3 quarters · filed 2024-08-13 | -$377.63K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $413.99K 10-Q · filed 2024-05-14 | $482.42K derived: sum of 2 quarters · filed 2024-05-14 | -$393.43K derived: sum of 3 quarters · filed 2024-05-14 | $256.25K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $68.43K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$807.42K derived: sum of 2 quarters · filed 2024-03-28 | -$157.74K derived: sum of 3 quarters · filed 2024-03-28 | $83.27K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$875.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$226.16K derived: sum of 2 quarters · filed 2023-11-08 | $14.84K 10-Q · filed 2023-11-08 | $118.68K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $649.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $890.69K 10-Q · filed 2023-08-09 | $994.53K derived: sum of 3 quarters · filed 2023-08-09 | $886.43K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $241.00K 10-Q · filed 2023-05-10 | $241.00M 10-Q · filed 2022-05-12 | $344.85K derived: sum of 2 quarters · filed 2023-05-10 | $236.75K derived: sum of 3 quarters · filed 2023-05-10 | -$131.53M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $103.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$4.26K derived: sum of 2 quarters · filed 2023-03-29 | -$131.77M derived: sum of 3 quarters · filed 2023-03-29 | $31.79K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$108.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$131.87M derived: sum of 2 quarters · filed 2022-11-10 | -$72.05K 10-Q · filed 2022-11-10 | -$577.11K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$131.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $36.05K 10-Q · filed 2022-08-10 | -$469.01K derived: sum of 3 quarters · filed 2022-08-10 | -$295.20K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $131.80M 10-Q · filed 2022-05-12 | $131.80K 10-Q · filed 2021-05-13 | $131.29M derived: sum of 2 quarters · filed 2022-05-12 | $131.47M derived: sum of 3 quarters · filed 2022-05-12 | $131.47M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$505.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$331.25K derived: sum of 2 quarters · filed 2022-03-29 | -$328.11K derived: sum of 3 quarters · filed 2022-03-29 | -$363.37K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $173.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $176.96K derived: sum of 2 quarters · filed 2021-11-10 | $141.70K 10-Q · filed 2021-11-10 | $283.66K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $3.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$32.11K 10-Q · filed 2021-08-12 | $109.85K derived: sum of 3 quarters · filed 2021-08-12 | $31.41K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$35.26K 10-Q · filed 2021-05-13 | $106.71K derived: sum of 2 quarters · filed 2021-05-13 | $28.27K derived: sum of 3 quarters · filed 2021-05-13 | $110.73K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $141.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $63.53K derived: sum of 2 quarters · filed 2021-03-30 | $145.99K derived: sum of 3 quarters · filed 2021-03-30 | $252.77K 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$78.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $4.03K derived: sum of 2 quarters · filed 2020-11-12 | $110.81K 10-Q · filed 2020-11-12 | $237.37K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $82.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $189.25K 10-Q · filed 2020-08-13 | $315.80K derived: sum of 3 quarters · filed 2020-08-13 | $514.35K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $106.78K 10-Q · filed 2020-05-14 | $233.34K derived: sum of 2 quarters · filed 2020-05-14 | $431.89K derived: sum of 3 quarters · filed 2020-05-14 | $338.61K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $126.56K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $325.11K derived: sum of 2 quarters · filed 2020-03-30 | $231.82K derived: sum of 3 quarters · filed 2020-03-30 | $59.98K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $198.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $105.27K derived: sum of 2 quarters · filed 2019-11-13 | -$66.57K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$93.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$265.12K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$171.84K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$333.02K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |